Gjensidige Forsikring ASA (GJNSF)
USD 17.52
(0.0%)
USD 17.52
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.81 Billion | 2.26 Billion | 7.02 Billion | 7.33 Billion | -1.23 Billion | -2.3 Billion |
| Net Income | 4.13 Billion | 3.43 Billion | 7.14 Billion | 4.95 Billion | 6.55 Billion | 3.38 Billion |
| Depreciation & Amortization | 660.2 Million | 572.2 Million | 548.4 Million | 666.5 Million | 763.1 Million | 559.6 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 28.4 Million | 28.5 Million | 22.6 Million | 17.6 Million | 13.1 Million | 11.5 Million |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | -6.3 Million | -1.77 Billion | -685.2 Million | 1.69 Billion | -8.56 Billion | -5.12 Billion |
| Investing Cash Flow | -1.03 Billion | 2.75 Billion | -1.39 Billion | -513.2 Million | 4.82 Billion | -438.3 Million |
| Investments in PPE | -726 Million | -565.1 Million | -532.6 Million | -513.2 Million | -438.5 Million | -403.6 Million |
| Acquisitions | -311.6 Million | 3.31 Billion | -867 Million | - | 5.26 Billion | -34.7 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.00 | 5.3 Million | - | - | 5.26 Billion | - |
| Financing Cash Flow | -4.09 Billion | -4.17 Billion | -6.1 Billion | -6.43 Billion | -4 Billion | 2.9 Billion |
| Debt repayment | -358.5 Million | -59.3 Million | -1.06 Billion | -45.5 Million | -188.4 Million | -6.48 Billion |
| Dividends payments | -4.12 Billion | -3.84 Billion | -6.89 Billion | -6.12 Billion | -3.54 Billion | -3.54 Billion |
| Common Stock Repurchased | -20.7 Million | -22.3 Million | -23.4 Million | -13 Million | -9.2 Million | -11 Million |
| Common Stock Issuance | -337.8 Million | 81.6 Million | -1.04 Billion | 58.5 Million | 197.6 Million | - |
| Other Financing Activities | 749.9 Million | -326.8 Million | 2.92 Billion | -313.7 Million | -452.1 Million | -26.7 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 3.19 Billion | 2.34 Billion | 2.86 Billion | 2.41 Billion | 2.83 Billion | 2.68 Billion |
| Cash at end of period | 2.98 Billion | 3.19 Billion | 2.34 Billion | 2.86 Billion | 2.41 Billion | 2.36 Billion |
| Capital Expenditure | -726 Million | -565.1 Million | -532.6 Million | -513.2 Million | -438.5 Million | -403.6 Million |
| Effect of forex changes on cash | 35.5 Million | 8.3 Million | -33.5 Million | 58.6 Million | -6.1 Million | -7.9 Million |
| Net cash flow / Change in cash | -208.3 Million | 847.1 Million | -513 Million | 441.6 Million | -420.4 Million | -321.9 Million |
| Free Cash Flow | 4.08 Billion | 1.69 Billion | 6.49 Billion | 6.82 Billion | -1.67 Billion | -2.7 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 1.39 Billion | 821.5 Million | 1.11 Billion | 4.13 Billion | 827 Million |
| Depreciation & Amortization | - | - | - | 451.6 Million | 660.2 Million | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | 28.4 Million | 28.4 Million | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | - | -2.13 Billion | 3.65 Billion | -2.5 Billion | -6.3 Million | -716 Million |
| Investing Cash Flow | 36.2 Million | 20.1 Million | -204.4 Million | -390 Million | -1.03 Billion | -235.3 Million |
| Investments in PPE | - | 33.5 Million | -183.2 Million | -94 Million | -726 Million | -235.3 Million |
| Acquisitions | 6.7 Million | -13.4 Million | -21.2 Million | -296 Million | -311.6 Million | -15.6 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 29.5 Million | 33.5 Million | - | - | 1.00 | 15.6 Million |
| Financing Cash Flow | -128.5 Million | -4.48 Billion | 1.19 Billion | -136.9 Million | -4.09 Billion | 380.7 Million |
| Debt repayment | -56.5 Million | -55.9 Million | -484.7 Million | -46.6 Million | -358.5 Million | -459.3 Million |
| Dividends payments | - | -4.37 Billion | -21.2 Million | -50.8 Million | -4.12 Billion | -17.3 Million |
| Common Stock Repurchased | - | -8.1 Million | -4.7 Million | -4.9 Million | -20.7 Million | -6.9 Million |
| Common Stock Issuance | - | - | - | - | -337.8 Million | -452.4 Million |
| Other Financing Activities | -65.5 Million | 100 Thousand | 796.8 Million | -85.4 Million | 749.9 Million | 1.31 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 3.25 Billion | 8.46 Billion | 2.98 Billion | 4.36 Billion | 3.19 Billion | 4.15 Billion |
| Cash at end of period | 4.31 Billion | 3.25 Billion | 8.46 Billion | 2.98 Billion | 2.98 Billion | 4.36 Billion |
| Capital Expenditure | - | 33.5 Million | -183.2 Million | -94 Million | -726 Million | -235.3 Million |
| Effect of forex changes on cash | 31.6 Million | -11.4 Million | 13.5 Million | 34 Million | 35.5 Million | -45.1 Million |
| Net cash flow / Change in cash | 1.06 Billion | -5.21 Billion | 5.47 Billion | -1.38 Billion | -208.3 Million | 211.3 Million |
| Free Cash Flow | - | -709.1 Million | 4.29 Billion | -1 Billion | 4.08 Billion | -124.3 Million |
AXFOS
CHEMCON
4320
ABLZF
NTES
0R32